Home [41–60] << 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 >> [81–100]
List View
 | 
Citations
 | 
Details
   web
Muscat, R., & of the Pompidou Group Treatment Platform, M. (2009). Treatment systems overview (T. Agard, C. Lahmek, S. Bazarya, R. Muscat, & G. Welle-Strand, Eds.). Paris: Pompidou Group; Council of Europe.
Toggle visibility
Members of the Pompidou Group Treatment Platform, & various. (2008). Draft : treatment systems overview (T. Agard, S. Bazarya, R. Muscat, & G. Welle-Strand, Eds.). Paris: Pompidou Group; Council of Europe.
Toggle visibility
various. (2006). 10th European conference on rehabilitation and drug policy : book of proceedings (A. Tsiboukli, R. Armaos, & K. Yfanti, Eds.). Athens: Therapy Center for Dependent Individuals (Ketheaf).
Toggle visibility
various. (1995). Die Bedeutung eines Opiatantagonisten im Rehabilitationsprozess von Drogenabhängigen (D. Ladewig, Ed.). Riedstadt: Lywis-Verlag.
Toggle visibility
various. (2008). Spectra No. 71 : Programme development. Spectra : prevention and health promotion, (71; 11/2008), 4.
Toggle visibility
various. (2008). Spectra no. 71 : Développement de programme. Spectra : prévention et promotion de la santé, (71; 11/2008), 12.
Toggle visibility
various. (2008). Spectra Nr. 71 : Programmentwicklung. Spectra : Gesundheitsförderung und Prävention, (71; 11/2008), 12.
Toggle visibility
Rupp, M. (2007). Zwischen Partylöwe und patriarchalem Geschäftsführer. HR Today : das Schweizer Human Resource Management-Journal, (12; 12/2007), 36–37.
Toggle visibility
(1993). Heroinabhängigkeit : Kann Naltrexon den Rückfall verhindern? Medical tribune : internationale Wochenzeitung : Ausgabe für die Schweiz, 16(23.04.1993), 16.
Toggle visibility
Llosa, T. (1995). Cocalization : the standard low dose of oral cocaine used for treatment of cocaine dependence. Journal of chemical addictions, 6(1; 05/1995), 16.
Toggle visibility